{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T03:30:50Z","timestamp":1790134250857,"version":"4.0.1"},"reference-count":101,"publisher":"MDPI AG","issue":"19","license":[{"start":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T00:00:00Z","timestamp":1727136000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostics"],"abstract":"<jats:p>Inflammatory bowel disease (IBD) is a chronic inflammatory condition affecting the gastrointestinal tract with increasing rates of incidence and prevalence across the world. Complex inflammatory and prothrombotic pathophysiology in IBD makes venous thromboembolism (VTE) a common complication with significant morbidity and mortality. This risk is increased in pregnancy. As we continue to understand the pathogenesis of IBD, this article highlights the continued risk of VTE following discharge, for which there is currently no clear guidance, yet the risk of VTE remains high. Furthermore, we discuss this increased VTE risk in the context of pregnant IBD patients and the relevant current guidelines. Alongside this, medications that are used to manage IBD carry their own thrombotic risk, which clinicians should be aware of. Assessing VTE risks in IBD populations using newer medications should be a focus of future research.<\/jats:p>","DOI":"10.3390\/diagnostics14192112","type":"journal-article","created":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T08:54:17Z","timestamp":1727168057000},"page":"2112","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Controversies in Venous Thromboembolism Risk Assessment in Inflammatory Bowel Disease: A Narrative Review"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-9500-0390","authenticated-orcid":false,"given":"Nikhil","family":"Sharma","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, The Royal Wolverhampton NHS Trust, Wolverhampton WV10 0QP, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-9493-8238","authenticated-orcid":false,"given":"Pavit","family":"Tewatia","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, The Royal Wolverhampton NHS Trust, Wolverhampton WV10 0QP, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1192-9910","authenticated-orcid":false,"given":"Philip R.","family":"Harvey","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, The Royal Wolverhampton NHS Trust, Wolverhampton WV10 0QP, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1026-3173","authenticated-orcid":false,"given":"Aditi","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, The Royal Wolverhampton NHS Trust, Wolverhampton WV10 0QP, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,9,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1159\/000496728","article-title":"Management of Iron Deficiency Anemia in Inflammatory Bowel Disease","volume":"142","author":"Jimenez","year":"2019","journal-title":"Acta Haematol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1016\/S0140-6736(17)32448-0","article-title":"Worldwide Incidence and Prevalence of Inflammatory Bowel Disease in the 21st Century: A Systematic Review of Population-Based Studies","volume":"390","author":"Ng","year":"2017","journal-title":"Lancet"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1001\/archinte.167.9.935","article-title":"Risk Factors and Short-Term Mortality of Venous Thromboembolism Diagnosed in the Primary Care Setting in the United Kingdom","volume":"167","author":"Huerta","year":"2007","journal-title":"Arch. Intern. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1001\/archsurg.2011.297","article-title":"Increased Risk of Postoperative Deep Vein Thrombosis and Pulmonary Embolism in Patients with Inflammatory Bowel Disease: A Study of National Surgical Quality Improvement Program Patients","volume":"147","author":"Merrill","year":"2012","journal-title":"Arch. Surg."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.3748\/wjg.v26.i12.1231","article-title":"Venous Thromboembolism in Inflammatory Bowel Disease","volume":"26","author":"Cheng","year":"2020","journal-title":"World J. Gastroenterol."},{"key":"ref_6","first-page":"680","article-title":"The Risk of Venous Thromboembolic Events in Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis","volume":"34","author":"Arvanitakis","year":"2021","journal-title":"Ann. Gastroenterol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1111\/apt.12294","article-title":"Meta-Analysis: The Risk of Venous Thromboembolism in Patients with Inflammatory Bowel Disease","volume":"37","author":"Yuhara","year":"2013","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0140-6736(09)61963-2","article-title":"Venous Thromboembolism During Active Disease and Remission in Inflammatory Bowel Disease: A Cohort Study","volume":"375","author":"Grainge","year":"2010","journal-title":"Lancet"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1136\/gut.2010.228585","article-title":"Thromboembolic Risk Among Danish Children and Adults with Inflammatory Bowel Diseases: A Population-Based Nationwide Study","volume":"60","author":"Kappelman","year":"2011","journal-title":"Gut"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.14309\/ajg.0000000000001237","article-title":"Persistently High Rate of Venous Thromboembolic Disease in Inflammatory Bowel Disease: A Population-Based Study","volume":"116","author":"Bernstein","year":"2021","journal-title":"Am. J. Gastroenterol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1572-0241.2006.00943.x","article-title":"Inflammation and Coagulation in Inflammatory Bowel Disease: The Clot Thickens","volume":"102","author":"Danese","year":"2007","journal-title":"Am. J. Gastroenterol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"697","DOI":"10.7326\/0003-4819-143-10-200511150-00006","article-title":"Trends in the Incidence of Venous Thromboembolism During Pregnancy or Postpartum: A 30-year Population-Based Study","volume":"143","author":"Heit","year":"2005","journal-title":"Ann. Intern. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1160\/TH10-12-0823","article-title":"Venous Thromboembolism in Pregnant and Puerperal Women in Denmark 1995\u20132005. A National Cohort Study","volume":"106","author":"Virkus","year":"2011","journal-title":"Thromb. Haemost."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e17309","DOI":"10.1097\/MD.0000000000017309","article-title":"The Risk of Venous Thromboembolism in Women with Inflammatory Bowel Disease During Pregnancy and the Postpartum Period: A Systematic Review and Meta-Analysis","volume":"98","author":"Kim","year":"2019","journal-title":"Medicine"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1056\/NEJMoa1311485","article-title":"Risk of a Thrombotic Event After the 6-Week Postpartum Period","volume":"370","author":"Kamel","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Khan, I., Ullah, N., Zha, L., Bai, Y., Khan, A., Zhao, T., Che, T., and Zhang, C. (2019). Alteration of Gut Microbiota in Inflammatory Bowel Disease (IBD): Cause or Consequence? IBD Treatment Targeting the Gut Microbiome. Pathogens, 8.","DOI":"10.3390\/pathogens8030126"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1136\/gut.2010.216259","article-title":"Nod2 Is Essential for Temporal Development of Intestinal Microbial Communities","volume":"60","author":"Rehman","year":"2011","journal-title":"Gut"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Gala, D., Newsome, T., Roberson, N., Lee, S.M., Thekkanal, M., Shah, M., Kumar, V., Bandaru, P., and Gayam, V. (2022). Thromboembolic Events in Patients with Inflammatory Bowel Disease: A Comprehensive Overview. Diseases, 10.","DOI":"10.3390\/diseases10040073"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"759","DOI":"10.7150\/ijms.15688","article-title":"Tissue Factor: A Potent Stimulator of von Willebrand Factor Synthesis by Human Umbilical Vein Endothelial Cells","volume":"13","author":"Meiring","year":"2016","journal-title":"Int. J. Med. Sci."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1002\/ibd.20896","article-title":"Inflammatory Bowel Disease: A Paradigm for the Link Between Coagulation and Inflammation","volume":"15","author":"Yoshida","year":"2009","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1136\/gut.36.1.5","article-title":"Platelet Dysfunction: A New Dimension in Inflammatory Bowel Disease","volume":"36","author":"Collins","year":"1995","journal-title":"Gut"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0163-4453(05)80006-4","article-title":"The Platelet Count as a Simple Measure to Distinguish Inflammatory Bowel Disease from Infective Diarrhoea","volume":"22","author":"Harries","year":"1991","journal-title":"J. Infect."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1136\/gut.52.10.1435","article-title":"Activated Platelets are the Source of Elevated Levels of Soluble CD40 Ligand in the Circulation of Inflammatory Bowel Disease Patients","volume":"52","author":"Danese","year":"2003","journal-title":"Gut"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Dhaliwal, G., Patrone, M.V., and Bickston, S.J. (2023). Venous Thromboembolism in Patients with Inflammatory Bowel Disease. J. Clin. Med., 13.","DOI":"10.3390\/jcm13010251"},{"key":"ref_25","first-page":"367","article-title":"Cerebrovascular Complications of Inflammatory Bowel Disease","volume":"86","author":"Johns","year":"1991","journal-title":"Am. J. Gastroenterol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1097\/MIB.0b013e31827eea5f","article-title":"Portomesenteric Vein Thrombosis in Patients with Inflammatory Bowel Disease","volume":"19","author":"Landman","year":"2013","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/ana.410050405","article-title":"Cerebral and Retinal Vascular Complications of Inflammatory Bowel Disease","volume":"5","author":"Schneiderman","year":"1979","journal-title":"Ann. Neurol."},{"key":"ref_28","first-page":"806","article-title":"Clinical Presentation of Inflammatory Bowel Disease: A Prospective Study on the Role of Vascular Involvement and Extraintestinal Manifestations","volume":"7","author":"Papay","year":"2013","journal-title":"J. Crohn\u2019s Colitis"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.crohns.2011.01.011","article-title":"Comprehensive Study of Cardiovascular Morbidity in Hospitalized Inflammatory Bowel Disease Patients","volume":"5","author":"Sridhar","year":"2011","journal-title":"J. Crohn\u2019s Colitis"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1177\/1076029609360528","article-title":"Risk of Venous Thromboembolism with Inflammatory Bowel Disease","volume":"17","author":"Saleh","year":"2011","journal-title":"Clin. Appl. Thromb. Hemost."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1136\/gut.2003.025411","article-title":"Is Inflammatory Bowel Disease an Independent and Disease Specific Risk Factor for Thromboembolism?","volume":"53","author":"Miehsler","year":"2004","journal-title":"Gut"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"A208","DOI":"10.1136\/gut.2011.239301.438","article-title":"Inflammatory Bowel Disease Is More Common in Type 1 Diabetes Mellitus","volume":"60","author":"Leeds","year":"2011","journal-title":"Gut"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.cgh.2019.07.052","article-title":"Inflammatory Bowel Diseases Increase Risk of Type 2 Diabetes in a Nationwide Cohort Study","volume":"18","author":"Jess","year":"2020","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.thromres.2020.12.017","article-title":"Predictors of Venous Thromboembolism in Hospitalized Patients with Inflammatory Bowel Disease and Colon Cancer: A Retrospective Cohort Study","volume":"199","author":"Achebe","year":"2021","journal-title":"Thromb. Res."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.dld.2022.08.017","article-title":"Influence of Diabetes Mellitus on Inflammatory Bowel Disease Course and Treatment Outcomes. A Systematic Review with Meta-Analysis","volume":"55","author":"Fuschillo","year":"2023","journal-title":"Dig. Liver Dis."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.ijgo.2015.06.054","article-title":"A Systematic Review and Meta-Analysis of the Epidemiology and Burden of Venous Thromboembolism Among Pregnant Women","volume":"132","author":"Kourlaba","year":"2016","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/j.1538-7836.2008.02921.x","article-title":"Pregnancy, the Postpartum Period and Prothrombotic Defects: Risk of Venous Thrombosis in the MEGA Study","volume":"6","author":"Pomp","year":"2008","journal-title":"J. Thromb. Haemost."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.1182\/bloodadvances.2018024802","article-title":"American Society of Hematology 2018 Guidelines for Management of Venous Thromboembolism: Venous Thromboembolism in the Context of Pregnancy","volume":"2","author":"Bates","year":"2018","journal-title":"Blood Adv."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1055\/s-0037-1613085","article-title":"Inherited Thrombophilia and First Venous Thromboembolism During Pregnancy and Puerperium","volume":"87","author":"Martinelli","year":"2002","journal-title":"Thromb. Haemost."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1055\/s-0038-1648485","article-title":"Venous Thrombosis During Pregnancy: Leg and Trimester of Presentation","volume":"67","author":"Ginsberg","year":"1992","journal-title":"Thromb. Haemost."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.ajog.2005.11.008","article-title":"Venous Thromboembolism During Pregnancy and the Postpartum Period: Incidence, Risk Factors, and Mortality","volume":"194","author":"James","year":"2006","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.ajog.2004.11.037","article-title":"Thrombosis During Pregnancy and the Postpartum Period","volume":"193","author":"James","year":"2005","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/OGX.0000000000001043","article-title":"Venous Thromboembolism During Pregnancy and the Postpartum Period: Risk Factors, Diagnostic Testing, and Treatment","volume":"77","author":"Maughan","year":"2022","journal-title":"Obstet. Gynecol. Surv."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Ficheur, G., Caron, A., Beuscart, J.B., Ferret, L., Jung, Y.J., Garabedian, C., Beuscart, R., and Chazard, E. (2017). Case-Crossover Study to Examine the Change in Postpartum Risk of Pulmonary Embolism Over Time. BMC Pregnancy Childbirth, 17.","DOI":"10.1186\/s12884-017-1283-y"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1097\/AOG.0000000000000230","article-title":"Postpartum Venous Thromboembolism: Incidence and Risk Factors","volume":"123","author":"Tepper","year":"2014","journal-title":"Obstet. Gynecol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.cgh.2008.10.022","article-title":"Outcomes of Obstetric Hospitalizations among Women with Inflammatory Bowel Disease in the United States","volume":"7","author":"Nguyen","year":"2009","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MEG.0000000000000495","article-title":"Thromboembolism as an Important Complication of Inflammatory Bowel Disease","volume":"28","author":"Bollen","year":"2016","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/apt.13670","article-title":"Review Article: Acute Severe Ulcerative Colitis\u2014Evidence-Based Consensus Statements","volume":"44","author":"Chen","year":"2016","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1053\/j.gastro.2010.05.026","article-title":"Inflammatory Bowel Disease Is a Risk Factor for Recurrent Venous Thromboembolism","volume":"139","author":"Novacek","year":"2010","journal-title":"Gastroenterology"},{"key":"ref_50","unstructured":"(2024, May 29). Thrombosis and Embolism during Pregnancy and the Puerperium: Acute Management (Green-Top Guideline No. 37B). RCOG. Available online: https:\/\/www.rcog.org.uk\/guidance\/browse-all-guidance\/green-top-guidelines\/thrombosis-and-embolism-during-pregnancy-and-the-puerperium-acute-management-green-top-guideline-no-37b\/."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1136\/flgastro-2020-101459","article-title":"Standards for the Provision of Antenatal Care for Patients with Inflammatory Bowel Disease: Guidance Endorsed by the British Society of Gastroenterology and the British Maternal and Fetal Medicine Society","volume":"12","author":"Selinger","year":"2020","journal-title":"Frontline Gastroenterol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ecco-jcc\/jjad108","article-title":"ECCO Guidelines on Extraintestinal Manifestations in Inflammatory Bowel Disease","volume":"18","author":"Gordon","year":"2024","journal-title":"J. Crohn\u2019s Colitis"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"s1","DOI":"10.1136\/gutjnl-2019-318484","article-title":"British Society of Gastroenterology Consensus Guidelines on the Management of Inflammatory Bowel Disease in Adults","volume":"68","author":"Lamb","year":"2019","journal-title":"Gut"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"384","DOI":"10.14309\/ajg.0000000000000152","article-title":"ACG Clinical Guideline: Ulcerative Colitis in Adults","volume":"114","author":"Rubin","year":"2019","journal-title":"Am. J. Gastroenterol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1093\/ecco-jcc\/jjac112","article-title":"Venous Thromboembolism Following Discharge from Hospital in Patients Admitted for Inflammatory Bowel Disease","volume":"17","author":"Harvey","year":"2023","journal-title":"J. Crohn\u2019s Colitis"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.cgh.2019.07.028","article-title":"Acute Venous Thromboembolism Risk Highest Within 60 Days after Discharge from the Hospital in Patients with Inflammatory Bowel Diseases","volume":"18","author":"Faye","year":"2020","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1111\/apt.15010","article-title":"The Risk of Venous Thromboembolism during and after Hospitalisation in Patients with Inflammatory Bowel Disease Activity","volume":"48","author":"Chu","year":"2018","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/codi.14853","article-title":"Extended Thromboprophylaxis Following Colorectal Surgery in Patients with Inflammatory Bowel Disease: A Comprehensive Systematic Clinical Review","volume":"22","author":"McKechnie","year":"2020","journal-title":"Color. Dis."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s11605-022-05525-4","article-title":"Are IBD Patients Underscored When Determining Postoperative VTE Risk?","volume":"27","author":"Ore","year":"2023","journal-title":"J. Gastrointest. Surg."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/s41575-021-00492-8","article-title":"International Consensus on the Prevention of Venous and Arterial Thrombotic Events in Patients with Inflammatory Bowel Disease","volume":"18","author":"Olivera","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1177\/1076029616652724","article-title":"Drug-Induced Thrombophilic or Prothrombotic States: An Underestimated Clinical Problem That Involves Both Legal and Illegal Compounds","volume":"23","author":"Girolami","year":"2017","journal-title":"Clin. Appl. Thromb. Hemost."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/ncpgasthep0696","article-title":"Drug Insight: Aminosalicylates for the Treatment of IBD","volume":"4","author":"Nielsen","year":"2007","journal-title":"Nat. Clin. Pract. Gastroenterol. Hepatol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1046\/j.1365-2036.2000.00824.x","article-title":"Inhibition of Platelet Activation by 5-Aminosalicylic Acid in Inflammatory Bowel Disease","volume":"14","author":"Carty","year":"2000","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1111\/j.1749-6632.2000.tb05426.x","article-title":"Cytokine Activation of the HPA Axis","volume":"917","author":"Dunn","year":"2000","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1111\/jth.13265","article-title":"The Influence of Corticosteroids on Hemostasis in Healthy Subjects","volume":"14","author":"Majoor","year":"2016","journal-title":"J. Thromb. Haemost."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1093\/ecco-jcc\/jjx162","article-title":"Steroid but Not Biological Therapy Elevates the Risk of Venous Thromboembolic Events in Inflammatory Bowel Disease: A Meta-Analysis","volume":"12","author":"Sarlos","year":"2018","journal-title":"J. Crohn\u2019s Colitis"},{"key":"ref_67","first-page":"358","article-title":"Thiopurines and the Risk of Venous Thromboembolism in Inflammatory Bowel Disease","volume":"14","author":"Laredo","year":"2020","journal-title":"J. Crohn\u2019s Colitis"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/00054725-200407000-00007","article-title":"Formation of Platelet-Leukocyte Aggregates in Inflammatory Bowel Disease","volume":"10","author":"Peter","year":"2004","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"555","DOI":"10.5009\/gnl210190","article-title":"Venous Thromboembolism Risk in Asian Patients with Inflammatory Bowel Disease: A Population-Based Nationwide Inception Cohort Study","volume":"16","author":"Kim","year":"2022","journal-title":"Gut Liver"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.jbspin.2018.07.004","article-title":"Methotrexate Mechanism in Treatment of Rheumatoid Arthritis","volume":"86","author":"Friedman","year":"2019","journal-title":"Jt. Bone Spine"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1111\/j.1572-0241.2001.04127.x","article-title":"Hyperhomocysteinemia and Prevalence of Polymorphisms of Homocysteine Metabolism-Related Enzymes in Patients with Inflammatory Bowel Disease","volume":"96","author":"Papa","year":"2001","journal-title":"Am. J. Gastroenterol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"539.e7","DOI":"10.1016\/j.amjmed.2014.11.025","article-title":"Risk of Venous Thromboembolism in Patients with Rheumatoid Arthritis: Initiating Disease-Modifying Antirheumatic Drugs","volume":"128","author":"Kim","year":"2015","journal-title":"Am. J. Med."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.cgh.2012.12.026","article-title":"Sustained Clinical Benefit and Tolerability of Methotrexate Monotherapy after Thiopurine Therapy in Patients with Crohn\u2019s Disease","volume":"11","author":"Seinen","year":"2013","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Jang, D.I., Lee, A.H., Shin, H.Y., Song, H.R., Park, J.H., Kang, T.B., Lee, S.R., and Yang, S.H. (2021). The Role of Tumor Necrosis Factor Alpha (TNF-\u03b1) in Autoimmune Disease and Current TNF-\u03b1 Inhibitors in Therapeutics. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22052719"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1111\/joim.13735","article-title":"Does Cardiovascular Risk Matter in IBD Patients?","volume":"294","author":"Tilg","year":"2023","journal-title":"J. Intern. Med."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1097\/MCG.0000000000001290","article-title":"Successful Infliximab Treatment is Associated with Reversal of Clotting Abnormalities in Inflammatory Bowel Disease Patients","volume":"54","author":"Detrez","year":"2020","journal-title":"J. Clin. Gastroenterol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1097\/MIB.0000000000000301","article-title":"Short-Term Effect of Infliximab is Reflected in the Clot Lysis Profile of Patients with Inflammatory Bowel Disease: A Prospective Study","volume":"21","author":"Bollen","year":"2015","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.cgh.2014.07.017","article-title":"Increased Risk of Venous Thromboembolic Events with Corticosteroid vs Biologic Therapy for Inflammatory Bowel Disease","volume":"13","author":"Higgins","year":"2015","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1097\/MCG.0000000000000408","article-title":"Antitumor Necrosis Factor-\u03b1 Therapy Is Associated with Reduced Risk of Thromboembolic Events in Hospitalized Patients with Inflammatory Bowel Disease","volume":"50","author":"Tuskey","year":"2016","journal-title":"J. Clin. Gastroenterol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1136\/flgastro-2023-102400","article-title":"JAK Inhibitors for Inflammatory Bowel Disease: Recent Advances","volume":"15","author":"Honap","year":"2023","journal-title":"Frontline Gastroenterol."},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Zhang, J., Li, W., Gong, M., Gu, Y., Zhang, H., Dong, B., Guo, Q., Pang, X., Xiang, Q., and He, X. (2023). Risk of Venous Thromboembolism with Janus Kinase Inhibitors in Inflammatory Immune Diseases: A Systematic Review and Meta-Analysis. Front. Pharmacol., 14.","DOI":"10.3389\/fphar.2023.1189389"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1002\/art.41580","article-title":"Venous Thromboembolism Risk with JAK Inhibitors: A Meta-Analysis","volume":"73","author":"Yates","year":"2021","journal-title":"Arthritis Rheumatol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1001\/jamadermatol.2022.3516","article-title":"Association of Risk of Incident Venous Thromboembolism with Atopic Dermatitis and Treatment with Janus Kinase Inhibitors: A Systematic Review and Meta-Analysis","volume":"158","author":"Chen","year":"2022","journal-title":"JAMA Dermatol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1093\/ibd\/izab011","article-title":"Real-World Effectiveness and Safety of Tofacitinib in Patients with Ulcerative Colitis: Systematic Review with Meta-Analysis","volume":"28","author":"Taxonera","year":"2021","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1056\/NEJMoa2109927","article-title":"Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis","volume":"386","author":"Ytterberg","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1111\/apt.15514","article-title":"Venous Thromboembolic Events in the Tofacitinib Ulcerative Colitis Clinical Development Programme","volume":"50","author":"Sandborn","year":"2019","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1056\/NEJMoa2212728","article-title":"Upadacitinib Induction and Maintenance Therapy for Crohn\u2019s Disease","volume":"388","author":"Loftus","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"ref_88","first-page":"457","article-title":"Efficacy of Upadacitinib in a Long-Term Extension Study in Ulcerative Colitis","volume":"161","author":"Sandborn","year":"2021","journal-title":"Gastroenterology"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1093\/ecco-jcc\/jjad112","article-title":"Clinician\u2019s Guide to Using Ozanimod for the Treatment of Ulcerative Colitis","volume":"17","author":"Sands","year":"2023","journal-title":"J. Crohn\u2019s Colitis"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.cgh.2023.11.018","article-title":"Cardiovascular Safety of Ozanimod in Patients with Ulcerative Colitis: True North and Open-Label Extension Analyses","volume":"22","author":"Armuzzi","year":"2024","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1093\/ecco-jcc\/jjab012","article-title":"Long-Term Efficacy and Safety of Ozanimod in Moderately to Severely Active Ulcerative Colitis: Results from the Open-Label Extension of the Randomized, Phase 2 TOUCHSTONE Study","volume":"15","author":"Sandborn","year":"2021","journal-title":"J. Crohn\u2019s Colitis"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.3748\/wjg.v24.i17.1868","article-title":"Anti-Integrin Therapy for Inflammatory Bowel Disease","volume":"24","author":"Park","year":"2018","journal-title":"World J. Gastroenterol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1136\/gutjnl-2015-311079","article-title":"The Safety of Vedolizumab for Ulcerative Colitis and Crohn\u2019s Disease","volume":"66","author":"Colombel","year":"2017","journal-title":"Gut"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1038\/s41395-018-0162-0","article-title":"Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium","volume":"113","author":"Narula","year":"2018","journal-title":"Am. J. Gastroenterol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ejim.2019.06.006","article-title":"Vedolizumab is Effective and Safe in Real-Life Treatment of Inflammatory Bowel Diseases Outpatients: A Multicenter, Observational Study in Primary Inflammatory Bowel Disease Centers","volume":"66","author":"Tursi","year":"2019","journal-title":"Eur. J. Intern. Med."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1093\/ibd\/izx067","article-title":"Vedolizumab as Induction and Maintenance for Inflammatory Bowel Disease: 12-Month Effectiveness and Safety","volume":"24","author":"Christensen","year":"2018","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"S775","DOI":"10.14309\/01.ajg.0000953728.18083.ce","article-title":"S1022 Long Term Risk of Venous Thromboembolism in Patients with Crohn\u2019s Disease Treated With Biologics or Immunomodulators","volume":"118","author":"Facey","year":"2023","journal-title":"Am. J. Gastroenterol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1056\/NEJMoa033402","article-title":"Anti-Interleukin-12 Antibody for Active Crohn\u2019s Disease","volume":"351","author":"Mannon","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1080\/14712598.2020.1707800","article-title":"Effectiveness and Safety of Ustekinumab for the Treatment of Crohn\u2019s Disease in Real-Life Experiences: A Meta-Analysis of Observational Studies","volume":"20","author":"Macaluso","year":"2020","journal-title":"Expert Opin. Biol. Ther."},{"key":"ref_100","unstructured":"Janssen (2024, July 21). Tremfya\u00ae (Guselkumab) Studies Underscore Its Potential to Be the Only IL-23 Inhibitor to Offer Both Subcutaneous and Intravenous Dosing. Available online: https:\/\/www.janssen.com\/tremfyar-guselkumab-studies-underscore-its-potential-be-only-il-23-inhibitor-offer-both-subcutaneous."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"5668","DOI":"10.3748\/wjg.v29.i41.5668","article-title":"Inflammatory Bowel Diseases Patients Suffer from Significant Low Levels and Barriers to Physical Activity: The \u201cBE-FIT-IBD\u201d Study","volume":"29","author":"Gravina","year":"2023","journal-title":"World J. Gastroenterol."}],"container-title":["Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4418\/14\/19\/2112\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:01:24Z","timestamp":1760112084000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4418\/14\/19\/2112"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,24]]},"references-count":101,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2024,10]]}},"alternative-id":["diagnostics14192112"],"URL":"https:\/\/doi.org\/10.3390\/diagnostics14192112","relation":{},"ISSN":["2075-4418"],"issn-type":[{"value":"2075-4418","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,24]]}}}